1585 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Scordo
    Scordo
  4. Shah
    Shah
  5. Dahi
    Dahi
  6. Ponce
    Ponce
  7. Sauter
    Sauter
  8. Devlin
    Devlin
  9. Shah
    Shah
  10. Papadopoulos
    Papadopoulos

Groups

  1. CTCR Scholars (1585)
  2. Department of Medicine (1369)
  3. Hematologic Malignancies, Division of (1045)
  4. MSK Grad Students (989)
  5. Master of Science in Clinical and Translational Cancer Research (956)
  6. Center for Hematologic Malignancies (955)
  7. Survivorship Research (885)
  8. Bone Marrow Transplant (841)
  9. Epidemiology and Biostatistics (671)
  10. Biostatistics Service (608)
  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (846)
  2. Journal Article (546)
  3. Review (68)
  4. Research Letter (35)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (16)
  8. Book Section (10)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. CTCR Scholars (1585)
  2. Department of Medicine (1369)
  3. Hematologic Malignancies, Division of (1045)
  4. MSK Grad Students (989)
  5. Master of Science in Clinical and Translational Cancer Research (956)
  6. Center for Hematologic Malignancies (955)

More Groups

People
  1. Sergio Giralt (539)
  2. Miguel-Angel Perales (397)
  3. Michael Scordo (366)
  4. Gunjan Shah (321)
  5. Sean Devlin (321)
  6. Parastoo Dahi (294)

More People

Years
  1. 2025 (68)
  2. 2024 (227)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (294)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (140)
  4. Annals of Surgical Oncology (81)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (55)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (345)
  3. American Society of Clinical Oncology (153)
  4. Nature Publishing Group (130)
  5. Springer (98)
  6. American Association for Cancer Research (65)

More Publishers

Results (1585)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
    Journal Article

    Hickman, R. A.; Miller, A. M.; Holle, B. M.; Jee, J.; Liu, S. Y.; Ross, D.; Yu, H.; Riely, G. J.; Ombres, C.; Gewirtz, A. N.; more...
    Acta Neuropathologica Communications (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of olomorasib (LY3537982), a second-generation KRAS G12C inhibitor (G12Ci), in combination with pembrolizumab in patients with KRAS G12C-mutant advanced NSCLC
    Meeting Abstract

    Burns, T. F.; Dragnev, K. H.; Fujiwara, Y.; Murciano-Goroff, Y. R.; Lee, D. H.; Hollebecque, A.; Koyama, T.; Cassier, P. A.; Italiano, A.; Heist, R. S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Pan-tumor activity of olomorasib (LY3537982), a second-generation KRAS G12C inhibitor (G12Ci), in patients with KRAS G12C-mutant advanced solid tumors
    Meeting Abstract

    Heist, R. S.; Koyama, T.; Murciano-Goroff, Y. R.; Hollebecque, A.; Cassier, P. A.; Han, J. Y.; Tosi, D.; Sacher, A. G.; Burns, T. F.; Spira, A. I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 (trastuzumab imbotolimod) plus /- pertuzumab (P) in patients (pts) with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan (T-DXd)
    Meeting Abstract

    Pegram, M. D.; Calfa, C.; Chen, C.; Cortés Salgado, A.; Heeke, A. L.; Kang, I.; Pistilli, B.; Pohlmann, P. R.; Rugo, H. S.; Saura, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Study of ELU001, a C'Dot drug conjugate (CDC) targeting folate receptor α (FRα) overexpressing solid tumors
    Meeting Abstract

    Ma, W. W.; Tolcher, A. W.; Perez, C. A.; Hendrickson, A. E. W.; Orr, D. W.; Murciano-Goroff, Y. R.; Anders, C. K.; Hamilton, E. P.; Swisher, E. M.; Mathews, C. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors
    Meeting Abstract

    Park, W.; Zhang, J.; Dayyani, F.; Shan, J.; Liu, R.; Guo, R.; O'Reilly, E. M.; Liu, Z.; Gao, S.; Wu, X.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Shareable artificial intelligence to extract cancer outcomes from electronic health records
    Meeting Abstract

    Kehl, K. L.; Jee, J.; Pichotta, K.; Trukhanov, P.; Fong, C.; Waters, M.; Nichols, C.; Cerami, E.; Schrag, D.; Schultz, N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Biomarkers in a phase 1b study of investigational microbiome therapeutic SER-155 in adults undergoing allogeneic hematopoietic cell transplantation (allo-HCT)
    Meeting Abstract

    Ponce, D. M.; Pandian, S.; van den Brink, M. R. M.; Kosuri, S.; Khera, N.; DeFilipp, Z. M.; Tejura, B.; Lichter, D. I.; Chafee, M.; Bardhan, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights
    Meeting Abstract

    Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save